Plaque psoriasis Trials in San Diego, United States
Conditions / Plaque psoriasis / San Diego, United States
Plaque psoriasis has been the subject of sustained clinical investigation across multiple research sites.
51 total trials for this combination
Showing top 10 of 51 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06108544 | A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period | COMPLETED | PHASE3 |
| NCT03573323 | A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis | COMPLETED | PHASE4 |
| NCT06095115 | A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06846541 | Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00570986 | A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT01708629 | Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects | TERMINATED | PHASE3 |
| NCT02826603 | Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT02513550 | A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT06550076 | A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT07116967 | Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) | RECRUITING | PHASE3 |